<DOC>
	<DOCNO>NCT00986596</DOCNO>
	<brief_summary>The purpose study investigate effect vitamin D muscle tissue physical performance .</brief_summary>
	<brief_title>A Pilot Study Impact Vitamin D3 Muscle Performance Elderly Women</brief_title>
	<detailed_description>The investigator recently observe among healthy woman age 65 old participate placebo-controlled vitamin D calcium intervention trial , treat supplement low risk fall placebo group . Vitamin D receptor ( VDRs ) present muscle tissue think mediate favorable effect vitamin D muscle performance . Vitamin D insufficiency common particularly elderly supplementation relatively high dose vitamin D may useful approach improve muscle performance potentially lower risk fall sedentary old woman high-risk population . The investigator aim study woman , age 65 old , 25 ( OH ) D level 60 nmol/l double-blind , 4-month randomize control pilot study . Eligible subject randomize treatment 4000 IU per day vitamin D3 placebo . Blood 24 hour urine measure begin end study outline intervention measurement schedule . In addition , safety random spot urine analyzed calcium creatinine day 30 . Muscle performance measure measure muscle biopsy perform begin end study .</detailed_description>
	<mesh_term>Sarcopenia</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<mesh_term>Cholecalciferol</mesh_term>
	<criteria>Age 65 old 25 ( OH ) D level &gt; 22.5 nmol/l &lt; 60 nmol/l Women must composite physical performance score â‰¤ 9 possible score 12 . Subjects must agree change usual level physical activity change amount calcium vitamin D supplement use duration study . If take calcium supplement , must agree take supplement time lunch . General : 1 . Total calcium intake &gt; 1000mg daily prescreening questionnaire . 2 . More 400 IU daily supplemental vitamin D prescreening questionnaire . 3 . A screen 25 ( OH ) D level &gt; 60 nmol/ L. 4 . Screening 24hour urine calcium &gt; 275 mg. 5 . An abnormal serum calcium . 6 . Travel latitude &lt; 35 degree N within 2 month time enrollment ; plan travel latitude &lt; 35 degree N 4month study , likelihood tanning ( e.g . appreciable sun exposure without sun screen ) . 7 . Greater 2 drink alcohol day . Medications : 1 . Bone active drug bisphosphonates , estrogen , calcitonin , teriparatide 2 . Diuretics 3 . Oral glucocorticoid last month 4 . Phosphates last week 5 . Lithium 6 . Cod liver oil 7 . Total parenteral nutrition 8 . Calcium contain antacid 9 . Coumadin prescribe anticoagulant Diseases : 1 . Active thyroid disease unstable levothyroxine dose 2 . Parathyroid disease 3 . Sarcoidosis 4 . Fracture foot , leg , hip last year 5 . Renal stone &lt; 5 year 6 . Alkaline phosphatase &gt; 10 % upper limit normal 7 . Pancreatitis 8 . Active malignancy ( basal cell cancer skin ) cancer therapy last year 9 . Uncontrolled arrhythmia last year 10 . Malabsorption 11 . Use walker wheelchair ( 3post cane okay ) 12 . Nasal oxygen use 13 . Must basic mobility level walk 4 meter 14 . Hemiplegia 15 . Tuberculosis 16 . Type 1 Diabetes mellitus unstable type 2 diabetes mellitus ( fast blood glucose &gt; 130 mg/dL ) 17 . Other abnormality screen lab , discretion study physician</criteria>
	<gender>Female</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2012</verification_date>
	<keyword>vitamin D</keyword>
	<keyword>skeletal muscle</keyword>
	<keyword>vitamin D receptor</keyword>
</DOC>